The anesthetic method has the potential to allow physicians to keep injuries from evolving into neuropathic pain, a chronic form of pain that arises from flawed signals transmitted to damaged nerves.
The team combined saxitoxin, a powerful local anesthetic, with dexamethasone to prolong saxitoxin’s effects. The two ingredients contain liposomes for nontoxic delivery to the site of nerve or tissue damage.
More Articles on Anesthesia:
Teleflex Receives Initial Clearance for Rusch EZ-Blocker
FDA: Discontinue Use of New England Compounding Center Products to Avoid Meningitis Contamination
Study: Lighter Anesthesia Does Not Improve Mortality Rates for Certain Patients
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
